These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
314 related articles for article (PubMed ID: 33455047)
21. Nigella sativa (black cumin) seed extract alleviates symptoms of allergic diarrhea in mice, involving opioid receptors. Duncker SC; Philippe D; Martin-Paschoud C; Moser M; Mercenier A; Nutten S PLoS One; 2012; 7(6):e39841. PubMed ID: 22768141 [TBL] [Abstract][Full Text] [Related]
22. Revisiting pharmacological potentials of Nigella sativa seed: A promising option for COVID-19 prevention and cure. Islam MN; Hossain KS; Sarker PP; Ferdous J; Hannan MA; Rahman MM; Chu DT; Uddin MJ Phytother Res; 2021 Mar; 35(3):1329-1344. PubMed ID: 33047412 [TBL] [Abstract][Full Text] [Related]
23. Molecular mechanisms and signaling pathways of black cumin (Nigella sativa) and its active constituent, thymoquinone: a review. Sadeghi E; Imenshahidi M; Hosseinzadeh H Mol Biol Rep; 2023 Jun; 50(6):5439-5454. PubMed ID: 37155017 [TBL] [Abstract][Full Text] [Related]
24. Nigella sativa: reduces the risk of various maladies. Butt MS; Sultan MT Crit Rev Food Sci Nutr; 2010 Aug; 50(7):654-65. PubMed ID: 20694927 [TBL] [Abstract][Full Text] [Related]
26. Therapeutic perspectives of the black cumin component thymoquinone: A review. Sarkar C; Jamaddar S; Islam T; Mondal M; Islam MT; Mubarak MS Food Funct; 2021 Jul; 12(14):6167-6213. PubMed ID: 34085672 [TBL] [Abstract][Full Text] [Related]
27. Overview of the preclinical pharmacological properties of Nigella sativa (black seeds): a complementary drug with historical and clinical significance. Dajani EZ; Shahwan TG; Dajani NE J Physiol Pharmacol; 2016 Dec; 67(6):801-817. PubMed ID: 28195061 [TBL] [Abstract][Full Text] [Related]
28. Pharmacological effects of Zataria multiflora Boiss L. and its constituents focus on their anti-inflammatory, antioxidant, and immunomodulatory effects. Khazdair MR; Ghorani V; Alavinezhad A; Boskabady MH Fundam Clin Pharmacol; 2018 Feb; 32(1):26-50. PubMed ID: 29125648 [TBL] [Abstract][Full Text] [Related]
29. Therapeutic and Phytochemical Properties of Thymoquinone Derived from Tiwari G; Gupta M; Devhare LD; Tiwari R Curr Drug Res Rev; 2024; 16(2):145-156. PubMed ID: 37605475 [TBL] [Abstract][Full Text] [Related]
30. The Protective Effect of α-Hederin, the Active Constituent of Nigella sativa, on Lung Inflammation and Blood Cytokines in Ovalbumin Sensitized Guinea Pigs. Keyhanmanesh R; Saadat S; Mohammadi M; Shahbazfar AA; Fallahi M Phytother Res; 2015 Nov; 29(11):1761-7. PubMed ID: 26292851 [TBL] [Abstract][Full Text] [Related]
31. Role of Nigella sativa and a number of its antioxidant constituents towards azoxymethane-induced genotoxic effects and colon cancer in rats. Al-Johar D; Shinwari N; Arif J; Al-Sanea N; Jabbar AA; El-Sayed R; Mashhour A; Billedo G; El-Doush I; Al-Saleh I Phytother Res; 2008 Oct; 22(10):1311-23. PubMed ID: 18570215 [TBL] [Abstract][Full Text] [Related]
32. Pharmacological and toxicological properties of Nigella sativa. Ali BH; Blunden G Phytother Res; 2003 Apr; 17(4):299-305. PubMed ID: 12722128 [TBL] [Abstract][Full Text] [Related]
33. Mitigation of obesity-promoted diseases by Nigella sativa and thymoquinone. Vanamala J; Kester AC; Heuberger AL; Reddivari L Plant Foods Hum Nutr; 2012 Jun; 67(2):111-9. PubMed ID: 22477645 [TBL] [Abstract][Full Text] [Related]
34. Immunomodulatory and Anti-inflammatory Effects of Thymoquinone. Shaterzadeh-Yazdi H; Noorbakhsh MF; Hayati F; Samarghandian S; Farkhondeh T Cardiovasc Hematol Disord Drug Targets; 2018; 18(1):52-60. PubMed ID: 29437018 [TBL] [Abstract][Full Text] [Related]
35. Dermaceutical Utilization of Nigella sativa Seeds: Applications and Opportunities. Khatoon M; Kushwaha P; Usmani S; Madan K Drug Res (Stuttg); 2024 Jan; 74(1):5-17. PubMed ID: 38016656 [TBL] [Abstract][Full Text] [Related]
36. Phytochemistry, pharmacology, and therapeutic uses of black seed (Nigella sativa). Kooti W; Hasanzadeh-Noohi Z; Sharafi-Ahvazi N; Asadi-Samani M; Ashtary-Larky D Chin J Nat Med; 2016 Oct; 14(10):732-745. PubMed ID: 28236403 [TBL] [Abstract][Full Text] [Related]
37. Effect of Nigella sativa and its bioactive compound on type 2 epithelial to mesenchymal transition: a systematic review. Nordin A; Kamal H; Yazid MD; Saim A; Idrus R BMC Complement Altern Med; 2019 Oct; 19(1):290. PubMed ID: 31666058 [TBL] [Abstract][Full Text] [Related]
38. Review: Nigella sativa (Prophetic Medicine): A Review. Ijaz H; Tulain UR; Qureshi J; Danish Z; Musayab S; Akhtar MF; Saleem A; Khan KK; Zaman M; Waheed I; Khan I; Abdel-Daim M Pak J Pharm Sci; 2017 Jan; 30(1):229-234. PubMed ID: 28603137 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of antifungal activities of the essential oil and various extracts of Nigella sativa and its main component, thymoquinone against pathogenic dermatophyte strains. Mahmoudvand H; Sepahvand A; Jahanbakhsh S; Ezatpour B; Ayatollahi Mousavi SA J Mycol Med; 2014 Dec; 24(4):e155-61. PubMed ID: 25442918 [TBL] [Abstract][Full Text] [Related]
40. Black Cumin (Nigella sativa) and Its Active Constituent, Thymoquinone: An Overview on the Analgesic and Anti-inflammatory Effects. Amin B; Hosseinzadeh H Planta Med; 2016 Jan; 82(1-2):8-16. PubMed ID: 26366755 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]